Elena Stylianou

Old Road Campus Research Building, Roosevelt Drive
Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Correction: Domain arrangement-driven immunogenicity of a computationally designed mRNA vaccine targeting PPE68, IrtA, and PE9 of Mycobacterium tuberculosis.

Correction: Domain arrangement-driven immunogenicity of a computationally designed mRNA vaccine targeting PPE68, IrtA, and PE9 of Mycobacterium tuberculosis.

Journal: Scientific reports

Published: July 27, 2026

Enhancing tuberculosis vaccine efficacy with a heterologous mRNA-ChAdOx1 prime-pull strategy targeting lung-resident memory T cells.

Enhancing tuberculosis vaccine efficacy with a heterologous mRNA-ChAdOx1 prime-pull strategy targeting lung-resident memory T cells.

Journal: Frontiers in immunology

Published: February 09, 2026

Domain arrangement-driven immunogenicity of a computationally designed mRNA vaccine targeting PPE68, IrtA, and PE9 of Mycobacterium tuberculosis.

Domain arrangement-driven immunogenicity of a computationally designed mRNA vaccine targeting PPE68, IrtA, and PE9 of Mycobacterium tuberculosis.

Journal: Scientific reports

Published: November 04, 2025

Domain arrangement-driven immunogenicity of a computationally designed mRNA vaccine targeting PPE68, IrtA, and PE9 of Mycobacterium tuberculosis.

Domain arrangement-driven immunogenicity of a computationally designed mRNA vaccine targeting PPE68, IrtA, and PE9 of Mycobacterium tuberculosis.

Journal: Scientific reports

Published: November 04, 2025

The influence of murine cytomegalovirus infection on susceptibility to mycobacterial infection.

The influence of murine cytomegalovirus infection on susceptibility to mycobacterial infection.

Journal: iScience

Published: September 08, 2025

Editorial: Innate immune response and interaction with adaptive immunity: role in tuberculosis immunology/vaccinology.

Editorial: Innate immune response and interaction with adaptive immunity: role in tuberculosis immunology/vaccinology.

Journal: Frontiers in immunology

Published: April 10, 2025

MetE: a promising protective antigen for tuberculosis vaccine development.

MetE: a promising protective antigen for tuberculosis vaccine development.

Journal: Frontiers in immunology

Published: March 13, 2025

Novel mRNA vaccines induce potent immunogenicity and afford protection against tuberculosis.

Novel mRNA vaccines induce potent immunogenicity and afford protection against tuberculosis.

Journal: Frontiers in immunology

Published: December 05, 2024

Strong immune responses and robust protection following a novel protein in adjuvant tuberculosis vaccine candidate.

Strong immune responses and robust protection following a novel protein in adjuvant tuberculosis vaccine candidate.

Journal: Scientific reports

Published: September 24, 2024

Inhaled aerosol viral-vectored vaccines against tuberculosis.

Inhaled aerosol viral-vectored vaccines against tuberculosis.

Journal: Current opinion in virology

Published: January 18, 2024

Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a dose-escalation, randomised, controlled, phase 1 trial.

Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a dose-escalation, randomised, controlled, phase 1 trial.

Journal: The Lancet. Infectious diseases

Published: November 12, 2023

A five-antigen Esx-5a fusion delivered as a prime-boost regimen protects against M.tb challenge.

A five-antigen Esx-5a fusion delivered as a prime-boost regimen protects against M.tb challenge.

Journal: Frontiers in immunology

Published: July 19, 2023

Showing 1-12 of 42

Last Updated: 09/26/2026